NCT00106912View on ClinicalTrials.gov

Study to Collect Data on Fabry Disease Patients With Enhanceable Alpha-Galactosidase A Activity

CompletedOBSERVATIONAL
Enrollment

35

Participants

Timeline

Start Date

March 28, 2005

Study Completion Date

March 27, 2008

Conditions
Fabry Disease
Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

NCT00106912 - Study to Collect Data on Fabry Disease Patients With Enhanceable Alpha-Galactosidase A Activity | Biotech Hunter | Biotech Hunter